
Keywords: Glutamate; Antidepressant; Anxiolytic; Analgesic; Ketamine; STAR*D; Receptor occupancy; MOA; mechanism of action; NAM; negative allosteric modulator; PPS; painful physical symptoms; MDD; major depressive disorder; STAR*D; sequenced treatment alternatives